CopyFind
Cevitram 250mg Tablet
medicine 📍 IN

Cevitram 250mg Tablet

54,30 ₹

Аналоги Cevitram 250mg Tablet

Знайдіть доступніші аналоги та дженерики для Cevitram 250mg Tablet.

Інгредієнти

Активний інгредієнт: Levetiracetam


Опис товару

About Cevitram

Cevitram is a medication containing the active ingredient Levetiracetam, classified as Medication. Levetiracetam, sold under the brand name Keppra among others, is an anti-seizure medication (medication) used to treat epilepsy. It is used for partial-onset, myoclonic, or tonic–clonic seizures, and is taken either by mouth as an immediate or extended release formulation or by injection into a vein.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1
  • Used for: 1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile.
  • Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Levetiracetam, the active ingredient in Cevitram, belongs to the Medication class. 1 INDICATIONS AND USAGE Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1. 1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy (1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Cevitram. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Cevitram for extended periods without medical advice.

Знайти в аптеках

Порівняйте місцеві ціни та відстань для Cevitram 250mg Tablet.

Оцінки відвідувачів

Допоможіть іншим — оцініть корисність цієї сторінки.

Оцінок ще немає — будьте першим.